We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-1.77%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$180M
AUM Growth
+$3.95M
Cap. Flow
+$10.6M
Cap. Flow %
5.89%
Top 10 Hldgs %
37.35%
Holding
45
New
7
Increased
15
Reduced
13
Closed
4

Top Buys

Rank Stock Value
1
WAT icon
Waters Corp
WAT
+$4.79M
2
RVTY icon
Revvity
RVTY
+$3.52M
3
BAX icon
Baxter International
BAX
+$3.31M
4
HCA icon
HCA Healthcare
HCA
+$2.99M
5
THC icon
Tenet Healthcare
THC
+$2.97M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$3.75M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$3.26M
3
CRL icon
Charles River Laboratories
CRL
+$3.21M
4
LHCG
LHC Group LLC
LHCG
+$3.12M
5
HUM icon
Humana
HUM
+$2.43M

Sector Composition

Rank Sector Weight
1 Healthcare 99.5%
2 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EHC icon
26
Encompass Health
EHC
$12.3B
$3.85M 2.14%
85,000
+3,295
+4% +$165K
OPCH icon
27
Option Care Health
OPCH
$3.57B
$3.46M 1.92%
110,000
+10,000
+10% +$320K
SGRY icon
28
Surgery Partners
SGRY
$2.01B
$3.24M 1.8%
138,609
+63,509
+85% +$2.03M
RVTY icon
29
Revvity
RVTY
$13.2B
$3.01M 1.67%
+25,000
New +$3.52M
ABT icon
30
Abbott
ABT
$192B
$2.9M 1.61%
30,000
-10,000
-25% -$1.07M
SEM
31
DELISTED
Select Medical
SEM
$2.87M 1.6%
241,280
+74,240
+44% +$1.05M
BIIB icon
32
Biogen
BIIB
$30.9B
$2.67M 1.48%
+10,000
New +$2.12M
MDT icon
33
Medtronic
MDT
$116B
$2.42M 1.35%
30,000
-10,000
-25% -$899K
AVTR icon
34
Avantor
AVTR
$9.42B
$1.96M 1.09%
100,000
– –
IQV icon
35
IQVIA
IQV
$39.8B
$1.81M 1.01%
10,000
-7,500
-43% -$1.64M
RPRX icon
36
Royalty Pharma
RPRX
$26.4B
$1.81M 1%
+45,008
New +$1.92M
AMED
37
DELISTED
Amedisys
AMED
$1.69M 0.94%
+17,500
New +$2.09M
SGEN
38
DELISTED
Seagen Inc. Common Stock
SGEN
$1.37M 0.76%
10,000
– –
INCY icon
39
Incyte
INCY
$24.5B
$1.25M 0.69%
+18,755
New +$1.39M
XBI icon
40
State Street SPDR S&P Biotech ETF
XBI
$10.5B
$895K 0.5%
11,284
-38,716
-77% -$3.26M
EHAB
41
DELISTED
Enhabit
EHAB
$879K 0.49%
+62,594
New +$1.01M
CRL icon
42
Charles River Laboratories
CRL
$13.6B
– –
-15,000
Closed -$3.21M
GRFS
43
Grifois
GRFS
$5.4B
– –
-100,000
Closed -$1.19M
SNY icon
44
Sanofi
SNY
$105B
– –
-75,000
Closed -$3.75M
LHCG
45
DELISTED
LHC Group LLC
LHCG
– –
-20,000
Closed -$3.12M
1
2

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM

Sivik Global Healthcare's Q3 2022 Portfolio in Review

As of Q3 2022, Sivik Global Healthcare held 45 positions worth $180M, up 2.2% from $176M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sivik Global Healthcare deployed $10.6M of net new capital in Q3 2022, opening 7 new positions and adding to 15 existing holdings. Its largest new stake was Waters Corp: 15,000 shares worth $4.04M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 96% a quarter earlier, followed by Energy.

On the sell side, the largest reduction was State Street SPDR S&P Biotech ETF, an estimated $3.26M trimmed.

  • Sivik Global Healthcare's largest Q3 2022 buy was Waters Corp: 15,000 shares worth $4.04M.
  • Sivik Global Healthcare added most to Baxter International in Q3 2022, an estimated $3.31M increase.
  • Sivik Global Healthcare's biggest Q3 2022 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $3.26M.
  • Sivik Global Healthcare fully exited Sanofi in Q3 2022, selling an estimated $3.75M.
  • Sivik Global Healthcare's ten largest holdings make up 37% of its $180M portfolio in Q3 2022.
  • Sivik Global Healthcare opened 7 new positions and closed 4 in Q3 2022.
  • Sivik Global Healthcare's portfolio value rose 2.2% quarter-over-quarter to $180M.

Based on Sivik Global Healthcare's 13F filing for Q3 2022, filed 4 Nov 2022.